AGC Biologics has unveiled the expansion of its pDNA Center of Excellence in Heidelberg, Germany. The global biopharmaceutical contract development and manufacturing organization (CDMO) is further expanding to meet the growing need for process development and manufacturing for plasmid DNA (pDNA).   “It is a priority to keep up with the growing demand for plasmid DNA offerings,” said Patricio Massera, chief executive officer, AGC Biologics.   The €1 million investment in a laboratory ...